This information is intended for Vermont Prescribers.
33 V.S.A. § 2005a.
PRODUCT NAME |
SHORT FORM |
LONG FORM |
DATE UPDATED |
---|---|---|---|
Aubagio® (teriflunomide) |
April 17, 2023 |
||
Cerdelga (eliglustat) |
April 17, 2023 |
||
Multaq (dronedarone) |
April 17, 2023 |
||
Rezurock™ (Belumosudil) |
April 17, 2023 |
Guide to Vermont's Pharmaceutical Marketer Price Disclosure Law, 33 V.S.A. § 2005a. Published by the Vermont Office of the Attorney General.
Please See Full Prescribing Information, including Boxed Warning, for Aubagio and Multaq.
MAT-US-2008477-v4.0-12/2021
Last Updated: December 2021